Tirzepatide: GLP-1/GIP

Tirzepatide is a dual-action peptide that acts on GLP-1 and GIP receptors. As part of a comprehensive, physician-supervised plan it may support appetite regulation, blood sugar control, and weight management. Compounded tirzepatide is prescribed following an individualized physician evaluation.

$399
Benefits of Tirzepatide
  • May support weight management when combined with lifestyle changes
  • May help with appetite and food cravings
  • May support insulin sensitivity and blood sugar regulation
  • May support metabolic health

‍

Usage Guidance
  • Cycle length: Typically prescribed in ongoing weekly injections, with dosing adjusted gradually
  • Dosing: Individualized by your provider to maximize effectiveness while minimizing side effects
  • Stacking: Sometimes combined with lifestyle interventions such as nutrition support, exercise programs, and other peptides to enhance results

‍

Who It May Help
  • Adults seeking medical support for weight loss or weight maintenance
  • People with obesity or overweight struggling to lose weight through diet and exercise alone
  • Individuals with insulin resistance or metabolic concerns
  • Patients seeking to improve energy, mobility, and long-term health outcomes

‍

What to Expect
  • Many patients notice appetite changes within the first weeks
  • Results typically build over several months as dosing progresses
  • Common experiences include smaller meal portions, steadier energy, and gradual changes in weight
  • Works well when paired with long-term lifestyle changes like balanced nutrition and regular physical activity

‍

Important Information

Compounded medications are not FDA-approved. They are prepared by appropriately licensed U.S. compounding pharmacies pursuant to a valid, patient-specific prescription when determined medically appropriate by the treating physician. Compounded tirzepatide is prescribed following an individualized physician evaluation, and individual results vary.